Estimation of PAMAM dendrimers' binding capacity by fluorescent probe ANS

Journal of Fluorescence

Volumn 13, Issue 6, 2003, Pages 519-524

  Shcharbin, D ^a   Klajnert, B ^b   Mazhul, V ^a   Bryszewska, M ^b  

^a INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

ANS; Binding capacity; Binding constant; Fluorometric titration; PAMAM dendrimers

Indexed keywords

BINDING ENERGY; CHEMICAL BONDS; MOLECULAR ORIENTATION; MONOMERS; PROTEINS; SYNTHESIS (CHEMICAL); TITRATION;

1-ANILINONAPTHALENE-8-SULFONIC ACID (ANS); BINDING CAPACITY; BINDING CONSTANTS; FLUOROMETRIC TITRATION; POLYAMIDOAMINE (PAMAM) DENDRIMERS;

DENDRIMERS;

EID: 3543106643     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOFL.0000008063.28420.45     Document Type: Article

References (18)

1. D. A. Tomalia, A. M. Naylor, and W. A. Goddard III (1990). Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. 29, 138-175.
2. M. Fisher and F. Vögtle (1999). Dendrimers: From design to application - A progress report. Angew. Chem. Int. Ed. 38, 884-905.
3. M. J. Cloninger (2002). Biological applications of dendrimers. Curr. Opin. Chem. Biol. 6, 742-748.
4. D. Zanini and R. Roy (1998). Practical synthesis of Starburst PA-MAM α-thiosialodendrimers for probing multivalent carbohydratelectin binding properties. J. Org. Chem. 63, 3486-3491.
5. C. Kojima, K. Kono, K. Maruyama, and T. Takagishi (2000). Synthesis of polyamidoamine dendrimers having polyethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem. 11, 910-917.
6. V. B. Gavrilov (2002). in I. D. Volotovski (Ed.), Biophysics of Living Systems: From Molecule to Organism, BelSens, Minsk, Belarus, pp. 134-147.
7. M. S. Highley and E. A. De Bruijn (1996). Erythrocytes and the transport of drugs and endogenous compounds. Pharm. Res. 13, 186-195.
8. U. Kragh-Hansen (1990). Structure and ligand binding properties of human serum albumin. Med. Bull. 37, 57-84.
9. Yu. A. Vladimirov and G. E. Dobretsov (1980). Fluorescent Probes in Studying Biological Membranes, Nauka, Moscow, Russia.
10. G. E. Dobretsov (1994). in Yu. A. Grizunov and G. E. Dobretsov (Eds.), Blood Serum Albumin in Clinical Medicine, Irius, Moscow, Russia.
11. M. A. Kiselev, Yu. A. Grizunov, G. E. Dobretsov, and M. N. Komarov (2001). The size of human serum albumin molecules in solution. Biophysics 46, 423-427.
12. G. Sudlow, D. J. Birkett, and D. N. Wade (1975). The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824-832.
13. M. A. Landau (1985). Molecular Nature of Some Physiological Processes, Nauka, Moscow, Russia.
14. G. Scatchard (1949). The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51, 660-672.
15. J. Slavik (1982). Anilinonaphthalene sulfonate as a probe of membrane composition and function. Biochim. Biophys. Acta 694, 1-25.
16. B. Klajnert, L. Stanisławska, M. Bryszewska, and B. Pałecz (2003). Interactions between PAMAM dendrimers and bovine serum albumin. Biochim. Biophys. Acta 1648, 115-126.
17. B. Klajnert and M. Bryszewska (2002). The interaction of tryptophan and ANS with PAMAM dendrimers. Cell. Mol. Biol. Lett. 7, 1087-1094.
18. A. M. Naylor and W. A. Goddard III (1989). Starburst dendrimers. 5. Molecular shape control. J. Am. Chem. Soc. III, 2339-2341.